nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—CYP19A1—osteoporosis	0.232	1	CbGaD
Paclitaxel—NR1I2—Ethinyl Estradiol—osteoporosis	0.0824	0.166	CbGbCtD
Paclitaxel—NR1I2—Estradiol—osteoporosis	0.0531	0.107	CbGbCtD
Paclitaxel—ABCC10—Estradiol—osteoporosis	0.0373	0.0753	CbGbCtD
Paclitaxel—ABCB11—Ethinyl Estradiol—osteoporosis	0.0315	0.0635	CbGbCtD
Paclitaxel—ABCC1—Zoledronate—osteoporosis	0.0295	0.0596	CbGbCtD
Paclitaxel—CYP19A1—Raloxifene—osteoporosis	0.0264	0.0533	CbGbCtD
Paclitaxel—SLCO1B3—Conjugated Estrogens—osteoporosis	0.0237	0.0479	CbGbCtD
Paclitaxel—SLCO1B3—Estradiol—osteoporosis	0.0208	0.0421	CbGbCtD
Paclitaxel—CYP1B1—Estradiol—osteoporosis	0.0203	0.0409	CbGbCtD
Paclitaxel—ABCC2—Ethinyl Estradiol—osteoporosis	0.0165	0.0334	CbGbCtD
Paclitaxel—ABCC1—Conjugated Estrogens—osteoporosis	0.0164	0.0331	CbGbCtD
Paclitaxel—ABCC2—Conjugated Estrogens—osteoporosis	0.0121	0.0245	CbGbCtD
Paclitaxel—ABCG2—Conjugated Estrogens—osteoporosis	0.011	0.0222	CbGbCtD
Paclitaxel—ABCG2—Estradiol—osteoporosis	0.00964	0.0195	CbGbCtD
Paclitaxel—CYP2C9—Estropipate—osteoporosis	0.00862	0.0174	CbGbCtD
Paclitaxel—CYP2C8—Raloxifene—osteoporosis	0.00825	0.0167	CbGbCtD
Paclitaxel—CYP2C8—Ethinyl Estradiol—osteoporosis	0.00797	0.0161	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.00712	0.0144	CbGbCtD
Paclitaxel—CYP3A7—Estradiol—osteoporosis	0.00712	0.0144	CbGbCtD
Paclitaxel—CYP2C8—Cholecalciferol—osteoporosis	0.00637	0.0129	CbGbCtD
Paclitaxel—ABCB1—Ethinyl Estradiol—osteoporosis	0.00539	0.0109	CbGbCtD
Paclitaxel—CYP3A5—Estradiol—osteoporosis	0.00534	0.0108	CbGbCtD
Paclitaxel—CYP2C8—Estradiol—osteoporosis	0.00513	0.0104	CbGbCtD
Paclitaxel—CYP3A4—Estropipate—osteoporosis	0.00501	0.0101	CbGbCtD
Paclitaxel—CYP3A4—Calcitriol—osteoporosis	0.00501	0.0101	CbGbCtD
Paclitaxel—CYP2C9—Cholecalciferol—osteoporosis	0.00444	0.00897	CbGbCtD
Paclitaxel—CYP3A4—Ergocalciferol—osteoporosis	0.00401	0.0081	CbGbCtD
Paclitaxel—ABCB1—Conjugated Estrogens—osteoporosis	0.00396	0.00799	CbGbCtD
Paclitaxel—CYP2C9—Estradiol—osteoporosis	0.00358	0.00723	CbGbCtD
Paclitaxel—ABCB1—Estradiol—osteoporosis	0.00348	0.00702	CbGbCtD
Paclitaxel—CYP3A4—Raloxifene—osteoporosis	0.00335	0.00676	CbGbCtD
Paclitaxel—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00323	0.00653	CbGbCtD
Paclitaxel—CYP3A4—Cholecalciferol—osteoporosis	0.00258	0.00522	CbGbCtD
Paclitaxel—CYP3A4—Conjugated Estrogens—osteoporosis	0.00237	0.00479	CbGbCtD
Paclitaxel—CYP3A4—Estradiol—osteoporosis	0.00208	0.00421	CbGbCtD
Paclitaxel—BCL2—Fulvestrant—Estradiol—osteoporosis	0.00115	0.624	CbGdCrCtD
Paclitaxel—TUBB6—Fulvestrant—Estradiol—osteoporosis	0.000417	0.226	CbGdCrCtD
Paclitaxel—TUBB6—Levorphanol—Estradiol—osteoporosis	0.000276	0.149	CbGdCrCtD
Paclitaxel—Pruritus—Alendronate—osteoporosis	5.9e-05	0.000369	CcSEcCtD
Paclitaxel—Dyspepsia—Risedronate—osteoporosis	5.89e-05	0.000369	CcSEcCtD
Paclitaxel—Eye disorder—Estradiol—osteoporosis	5.89e-05	0.000369	CcSEcCtD
Paclitaxel—Tinnitus—Estradiol—osteoporosis	5.88e-05	0.000368	CcSEcCtD
Paclitaxel—Constipation—Ethinyl Estradiol—osteoporosis	5.87e-05	0.000367	CcSEcCtD
Paclitaxel—Confusional state—Zoledronate—osteoporosis	5.86e-05	0.000367	CcSEcCtD
Paclitaxel—Hypersensitivity—Calcitriol—osteoporosis	5.86e-05	0.000367	CcSEcCtD
Paclitaxel—Flushing—Estradiol—osteoporosis	5.85e-05	0.000366	CcSEcCtD
Paclitaxel—Cardiac disorder—Estradiol—osteoporosis	5.85e-05	0.000366	CcSEcCtD
Paclitaxel—Arthralgia—Conjugated Estrogens—osteoporosis	5.84e-05	0.000365	CcSEcCtD
Paclitaxel—Chest pain—Conjugated Estrogens—osteoporosis	5.84e-05	0.000365	CcSEcCtD
Paclitaxel—Myalgia—Conjugated Estrogens—osteoporosis	5.84e-05	0.000365	CcSEcCtD
Paclitaxel—Asthenia—Ibandronate—osteoporosis	5.83e-05	0.000365	CcSEcCtD
Paclitaxel—Anxiety—Conjugated Estrogens—osteoporosis	5.82e-05	0.000364	CcSEcCtD
Paclitaxel—Nausea—Etidronic acid—osteoporosis	5.82e-05	0.000364	CcSEcCtD
Paclitaxel—Anaphylactic shock—Zoledronate—osteoporosis	5.81e-05	0.000364	CcSEcCtD
Paclitaxel—Oedema—Zoledronate—osteoporosis	5.81e-05	0.000364	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	5.8e-05	0.000363	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Pamidronate—osteoporosis	5.8e-05	0.000363	CcSEcCtD
Paclitaxel—Diarrhoea—Estropipate—osteoporosis	5.8e-05	0.000363	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Risedronate—osteoporosis	5.78e-05	0.000362	CcSEcCtD
Paclitaxel—Infection—Zoledronate—osteoporosis	5.78e-05	0.000361	CcSEcCtD
Paclitaxel—Fatigue—Risedronate—osteoporosis	5.77e-05	0.000361	CcSEcCtD
Paclitaxel—Insomnia—Pamidronate—osteoporosis	5.76e-05	0.00036	CcSEcCtD
Paclitaxel—Pruritus—Ibandronate—osteoporosis	5.75e-05	0.00036	CcSEcCtD
Paclitaxel—Constipation—Risedronate—osteoporosis	5.73e-05	0.000358	CcSEcCtD
Paclitaxel—Pain—Risedronate—osteoporosis	5.73e-05	0.000358	CcSEcCtD
Paclitaxel—Angiopathy—Estradiol—osteoporosis	5.72e-05	0.000358	CcSEcCtD
Paclitaxel—Shock—Zoledronate—osteoporosis	5.72e-05	0.000358	CcSEcCtD
Paclitaxel—Paraesthesia—Pamidronate—osteoporosis	5.72e-05	0.000358	CcSEcCtD
Paclitaxel—Diarrhoea—Alendronate—osteoporosis	5.71e-05	0.000357	CcSEcCtD
Paclitaxel—Asthenia—Calcitriol—osteoporosis	5.71e-05	0.000357	CcSEcCtD
Paclitaxel—Nervous system disorder—Zoledronate—osteoporosis	5.7e-05	0.000357	CcSEcCtD
Paclitaxel—Immune system disorder—Estradiol—osteoporosis	5.7e-05	0.000356	CcSEcCtD
Paclitaxel—Thrombocytopenia—Zoledronate—osteoporosis	5.69e-05	0.000356	CcSEcCtD
Paclitaxel—Mediastinal disorder—Estradiol—osteoporosis	5.68e-05	0.000356	CcSEcCtD
Paclitaxel—Dyspnoea—Pamidronate—osteoporosis	5.67e-05	0.000355	CcSEcCtD
Paclitaxel—Tachycardia—Zoledronate—osteoporosis	5.67e-05	0.000355	CcSEcCtD
Paclitaxel—Feeling abnormal—Ethinyl Estradiol—osteoporosis	5.66e-05	0.000354	CcSEcCtD
Paclitaxel—Chills—Estradiol—osteoporosis	5.66e-05	0.000354	CcSEcCtD
Paclitaxel—Somnolence—Pamidronate—osteoporosis	5.66e-05	0.000354	CcSEcCtD
Paclitaxel—Skin disorder—Zoledronate—osteoporosis	5.65e-05	0.000353	CcSEcCtD
Paclitaxel—Pruritus—Calcitriol—osteoporosis	5.63e-05	0.000352	CcSEcCtD
Paclitaxel—Hyperhidrosis—Zoledronate—osteoporosis	5.62e-05	0.000352	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	5.62e-05	0.000351	CcSEcCtD
Paclitaxel—Diarrhoea—Raloxifene—osteoporosis	5.61e-05	0.000351	CcSEcCtD
Paclitaxel—Dyspepsia—Pamidronate—osteoporosis	5.6e-05	0.000351	CcSEcCtD
Paclitaxel—Dizziness—Estropipate—osteoporosis	5.6e-05	0.000351	CcSEcCtD
Paclitaxel—Anaphylactic shock—Conjugated Estrogens—osteoporosis	5.6e-05	0.00035	CcSEcCtD
Paclitaxel—Oedema—Conjugated Estrogens—osteoporosis	5.6e-05	0.00035	CcSEcCtD
Paclitaxel—Alopecia—Estradiol—osteoporosis	5.57e-05	0.000349	CcSEcCtD
Paclitaxel—Infection—Conjugated Estrogens—osteoporosis	5.56e-05	0.000348	CcSEcCtD
Paclitaxel—Diarrhoea—Ibandronate—osteoporosis	5.56e-05	0.000348	CcSEcCtD
Paclitaxel—Anorexia—Zoledronate—osteoporosis	5.54e-05	0.000347	CcSEcCtD
Paclitaxel—Decreased appetite—Pamidronate—osteoporosis	5.53e-05	0.000346	CcSEcCtD
Paclitaxel—Mental disorder—Estradiol—osteoporosis	5.52e-05	0.000346	CcSEcCtD
Paclitaxel—Dizziness—Alendronate—osteoporosis	5.52e-05	0.000345	CcSEcCtD
Paclitaxel—Shock—Conjugated Estrogens—osteoporosis	5.51e-05	0.000345	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Pamidronate—osteoporosis	5.49e-05	0.000344	CcSEcCtD
Paclitaxel—Nervous system disorder—Conjugated Estrogens—osteoporosis	5.49e-05	0.000343	CcSEcCtD
Paclitaxel—Erythema—Estradiol—osteoporosis	5.49e-05	0.000343	CcSEcCtD
Paclitaxel—Malnutrition—Estradiol—osteoporosis	5.49e-05	0.000343	CcSEcCtD
Paclitaxel—Fatigue—Pamidronate—osteoporosis	5.49e-05	0.000343	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Risedronate—osteoporosis	5.47e-05	0.000343	CcSEcCtD
Paclitaxel—Tachycardia—Conjugated Estrogens—osteoporosis	5.46e-05	0.000342	CcSEcCtD
Paclitaxel—Urticaria—Ethinyl Estradiol—osteoporosis	5.46e-05	0.000341	CcSEcCtD
Paclitaxel—Constipation—Pamidronate—osteoporosis	5.44e-05	0.000341	CcSEcCtD
Paclitaxel—Pain—Pamidronate—osteoporosis	5.44e-05	0.000341	CcSEcCtD
Paclitaxel—Diarrhoea—Calcitriol—osteoporosis	5.44e-05	0.00034	CcSEcCtD
Paclitaxel—Skin disorder—Conjugated Estrogens—osteoporosis	5.44e-05	0.00034	CcSEcCtD
Paclitaxel—Hypotension—Zoledronate—osteoporosis	5.43e-05	0.00034	CcSEcCtD
Paclitaxel—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.43e-05	0.00034	CcSEcCtD
Paclitaxel—Body temperature increased—Ethinyl Estradiol—osteoporosis	5.43e-05	0.00034	CcSEcCtD
Paclitaxel—Dizziness—Raloxifene—osteoporosis	5.43e-05	0.00034	CcSEcCtD
Paclitaxel—Hyperhidrosis—Conjugated Estrogens—osteoporosis	5.41e-05	0.000339	CcSEcCtD
Paclitaxel—Flatulence—Estradiol—osteoporosis	5.41e-05	0.000338	CcSEcCtD
Paclitaxel—Tension—Estradiol—osteoporosis	5.39e-05	0.000337	CcSEcCtD
Paclitaxel—Vomiting—Estropipate—osteoporosis	5.39e-05	0.000337	CcSEcCtD
Paclitaxel—Dysgeusia—Estradiol—osteoporosis	5.38e-05	0.000336	CcSEcCtD
Paclitaxel—Dizziness—Ibandronate—osteoporosis	5.37e-05	0.000336	CcSEcCtD
Paclitaxel—Rash—Estropipate—osteoporosis	5.34e-05	0.000334	CcSEcCtD
Paclitaxel—Dermatitis—Estropipate—osteoporosis	5.34e-05	0.000334	CcSEcCtD
Paclitaxel—Anorexia—Conjugated Estrogens—osteoporosis	5.34e-05	0.000334	CcSEcCtD
Paclitaxel—Nervousness—Estradiol—osteoporosis	5.33e-05	0.000334	CcSEcCtD
Paclitaxel—Urticaria—Risedronate—osteoporosis	5.32e-05	0.000333	CcSEcCtD
Paclitaxel—Back pain—Estradiol—osteoporosis	5.31e-05	0.000332	CcSEcCtD
Paclitaxel—Headache—Estropipate—osteoporosis	5.31e-05	0.000332	CcSEcCtD
Paclitaxel—Vomiting—Alendronate—osteoporosis	5.31e-05	0.000332	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Zoledronate—osteoporosis	5.3e-05	0.000331	CcSEcCtD
Paclitaxel—Abdominal pain—Risedronate—osteoporosis	5.29e-05	0.000331	CcSEcCtD
Paclitaxel—Body temperature increased—Risedronate—osteoporosis	5.29e-05	0.000331	CcSEcCtD
Paclitaxel—Muscle spasms—Estradiol—osteoporosis	5.28e-05	0.00033	CcSEcCtD
Paclitaxel—Rash—Alendronate—osteoporosis	5.26e-05	0.000329	CcSEcCtD
Paclitaxel—Insomnia—Zoledronate—osteoporosis	5.26e-05	0.000329	CcSEcCtD
Paclitaxel—Dermatitis—Alendronate—osteoporosis	5.26e-05	0.000329	CcSEcCtD
Paclitaxel—Feeling abnormal—Pamidronate—osteoporosis	5.24e-05	0.000328	CcSEcCtD
Paclitaxel—Hypotension—Conjugated Estrogens—osteoporosis	5.23e-05	0.000327	CcSEcCtD
Paclitaxel—Headache—Alendronate—osteoporosis	5.23e-05	0.000327	CcSEcCtD
Paclitaxel—Paraesthesia—Zoledronate—osteoporosis	5.22e-05	0.000327	CcSEcCtD
Paclitaxel—Vomiting—Raloxifene—osteoporosis	5.22e-05	0.000326	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Pamidronate—osteoporosis	5.2e-05	0.000326	CcSEcCtD
Paclitaxel—Dyspnoea—Zoledronate—osteoporosis	5.18e-05	0.000324	CcSEcCtD
Paclitaxel—Rash—Raloxifene—osteoporosis	5.17e-05	0.000324	CcSEcCtD
Paclitaxel—Dermatitis—Raloxifene—osteoporosis	5.17e-05	0.000323	CcSEcCtD
Paclitaxel—Somnolence—Zoledronate—osteoporosis	5.17e-05	0.000323	CcSEcCtD
Paclitaxel—Vomiting—Ibandronate—osteoporosis	5.17e-05	0.000323	CcSEcCtD
Paclitaxel—Tremor—Estradiol—osteoporosis	5.14e-05	0.000322	CcSEcCtD
Paclitaxel—Headache—Raloxifene—osteoporosis	5.14e-05	0.000322	CcSEcCtD
Paclitaxel—Rash—Ibandronate—osteoporosis	5.12e-05	0.00032	CcSEcCtD
Paclitaxel—Dermatitis—Ibandronate—osteoporosis	5.12e-05	0.00032	CcSEcCtD
Paclitaxel—Dyspepsia—Zoledronate—osteoporosis	5.12e-05	0.00032	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	5.1e-05	0.000319	CcSEcCtD
Paclitaxel—Ill-defined disorder—Estradiol—osteoporosis	5.09e-05	0.000319	CcSEcCtD
Paclitaxel—Headache—Ibandronate—osteoporosis	5.09e-05	0.000318	CcSEcCtD
Paclitaxel—Insomnia—Conjugated Estrogens—osteoporosis	5.06e-05	0.000317	CcSEcCtD
Paclitaxel—Hypersensitivity—Ethinyl Estradiol—osteoporosis	5.06e-05	0.000317	CcSEcCtD
Paclitaxel—Vomiting—Calcitriol—osteoporosis	5.06e-05	0.000316	CcSEcCtD
Paclitaxel—Decreased appetite—Zoledronate—osteoporosis	5.05e-05	0.000316	CcSEcCtD
Paclitaxel—Agitation—Estradiol—osteoporosis	5.04e-05	0.000316	CcSEcCtD
Paclitaxel—Nausea—Estropipate—osteoporosis	5.03e-05	0.000315	CcSEcCtD
Paclitaxel—Body temperature increased—Pamidronate—osteoporosis	5.03e-05	0.000315	CcSEcCtD
Paclitaxel—Abdominal pain—Pamidronate—osteoporosis	5.03e-05	0.000315	CcSEcCtD
Paclitaxel—Paraesthesia—Conjugated Estrogens—osteoporosis	5.03e-05	0.000314	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Zoledronate—osteoporosis	5.02e-05	0.000314	CcSEcCtD
Paclitaxel—Angioedema—Estradiol—osteoporosis	5.02e-05	0.000314	CcSEcCtD
Paclitaxel—Rash—Calcitriol—osteoporosis	5.01e-05	0.000314	CcSEcCtD
Paclitaxel—Fatigue—Zoledronate—osteoporosis	5.01e-05	0.000314	CcSEcCtD
Paclitaxel—Dermatitis—Calcitriol—osteoporosis	5.01e-05	0.000313	CcSEcCtD
Paclitaxel—Dyspnoea—Conjugated Estrogens—osteoporosis	4.99e-05	0.000312	CcSEcCtD
Paclitaxel—Headache—Calcitriol—osteoporosis	4.98e-05	0.000312	CcSEcCtD
Paclitaxel—Somnolence—Conjugated Estrogens—osteoporosis	4.98e-05	0.000311	CcSEcCtD
Paclitaxel—Pain—Zoledronate—osteoporosis	4.97e-05	0.000311	CcSEcCtD
Paclitaxel—Constipation—Zoledronate—osteoporosis	4.97e-05	0.000311	CcSEcCtD
Paclitaxel—Nausea—Alendronate—osteoporosis	4.96e-05	0.00031	CcSEcCtD
Paclitaxel—Malaise—Estradiol—osteoporosis	4.95e-05	0.00031	CcSEcCtD
Paclitaxel—Hypersensitivity—Risedronate—osteoporosis	4.93e-05	0.000309	CcSEcCtD
Paclitaxel—Vertigo—Estradiol—osteoporosis	4.93e-05	0.000309	CcSEcCtD
Paclitaxel—Dyspepsia—Conjugated Estrogens—osteoporosis	4.93e-05	0.000308	CcSEcCtD
Paclitaxel—Asthenia—Ethinyl Estradiol—osteoporosis	4.93e-05	0.000308	CcSEcCtD
Paclitaxel—Syncope—Estradiol—osteoporosis	4.92e-05	0.000308	CcSEcCtD
Paclitaxel—Nausea—Raloxifene—osteoporosis	4.87e-05	0.000305	CcSEcCtD
Paclitaxel—Decreased appetite—Conjugated Estrogens—osteoporosis	4.87e-05	0.000304	CcSEcCtD
Paclitaxel—Pruritus—Ethinyl Estradiol—osteoporosis	4.86e-05	0.000304	CcSEcCtD
Paclitaxel—Palpitations—Estradiol—osteoporosis	4.85e-05	0.000304	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	4.83e-05	0.000302	CcSEcCtD
Paclitaxel—Fatigue—Conjugated Estrogens—osteoporosis	4.83e-05	0.000302	CcSEcCtD
Paclitaxel—Nausea—Ibandronate—osteoporosis	4.83e-05	0.000302	CcSEcCtD
Paclitaxel—Loss of consciousness—Estradiol—osteoporosis	4.82e-05	0.000302	CcSEcCtD
Paclitaxel—Asthenia—Risedronate—osteoporosis	4.8e-05	0.000301	CcSEcCtD
Paclitaxel—Feeling abnormal—Zoledronate—osteoporosis	4.79e-05	0.0003	CcSEcCtD
Paclitaxel—Cough—Estradiol—osteoporosis	4.79e-05	0.0003	CcSEcCtD
Paclitaxel—Pain—Conjugated Estrogens—osteoporosis	4.79e-05	0.0003	CcSEcCtD
Paclitaxel—Constipation—Conjugated Estrogens—osteoporosis	4.79e-05	0.0003	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Zoledronate—osteoporosis	4.75e-05	0.000297	CcSEcCtD
Paclitaxel—Hypertension—Estradiol—osteoporosis	4.74e-05	0.000297	CcSEcCtD
Paclitaxel—Pruritus—Risedronate—osteoporosis	4.74e-05	0.000296	CcSEcCtD
Paclitaxel—Nausea—Calcitriol—osteoporosis	4.72e-05	0.000296	CcSEcCtD
Paclitaxel—Diarrhoea—Ethinyl Estradiol—osteoporosis	4.7e-05	0.000294	CcSEcCtD
Paclitaxel—Hypersensitivity—Pamidronate—osteoporosis	4.69e-05	0.000293	CcSEcCtD
Paclitaxel—Chest pain—Estradiol—osteoporosis	4.67e-05	0.000292	CcSEcCtD
Paclitaxel—Myalgia—Estradiol—osteoporosis	4.67e-05	0.000292	CcSEcCtD
Paclitaxel—Arthralgia—Estradiol—osteoporosis	4.67e-05	0.000292	CcSEcCtD
Paclitaxel—Anxiety—Estradiol—osteoporosis	4.66e-05	0.000291	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	4.64e-05	0.00029	CcSEcCtD
Paclitaxel—Urticaria—Zoledronate—osteoporosis	4.62e-05	0.000289	CcSEcCtD
Paclitaxel—Discomfort—Estradiol—osteoporosis	4.62e-05	0.000289	CcSEcCtD
Paclitaxel—Abdominal pain—Zoledronate—osteoporosis	4.6e-05	0.000288	CcSEcCtD
Paclitaxel—Body temperature increased—Zoledronate—osteoporosis	4.6e-05	0.000288	CcSEcCtD
Paclitaxel—Diarrhoea—Risedronate—osteoporosis	4.58e-05	0.000287	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	4.58e-05	0.000286	CcSEcCtD
Paclitaxel—Dry mouth—Estradiol—osteoporosis	4.57e-05	0.000286	CcSEcCtD
Paclitaxel—Asthenia—Pamidronate—osteoporosis	4.57e-05	0.000286	CcSEcCtD
Paclitaxel—Dizziness—Ethinyl Estradiol—osteoporosis	4.54e-05	0.000284	CcSEcCtD
Paclitaxel—Confusional state—Estradiol—osteoporosis	4.52e-05	0.000283	CcSEcCtD
Paclitaxel—Pruritus—Pamidronate—osteoporosis	4.5e-05	0.000282	CcSEcCtD
Paclitaxel—Oedema—Estradiol—osteoporosis	4.48e-05	0.00028	CcSEcCtD
Paclitaxel—Anaphylactic shock—Estradiol—osteoporosis	4.48e-05	0.00028	CcSEcCtD
Paclitaxel—Infection—Estradiol—osteoporosis	4.45e-05	0.000278	CcSEcCtD
Paclitaxel—Urticaria—Conjugated Estrogens—osteoporosis	4.45e-05	0.000278	CcSEcCtD
Paclitaxel—Dizziness—Risedronate—osteoporosis	4.43e-05	0.000277	CcSEcCtD
Paclitaxel—Abdominal pain—Conjugated Estrogens—osteoporosis	4.43e-05	0.000277	CcSEcCtD
Paclitaxel—Body temperature increased—Conjugated Estrogens—osteoporosis	4.43e-05	0.000277	CcSEcCtD
Paclitaxel—Shock—Estradiol—osteoporosis	4.41e-05	0.000276	CcSEcCtD
Paclitaxel—Nervous system disorder—Estradiol—osteoporosis	4.39e-05	0.000275	CcSEcCtD
Paclitaxel—Tachycardia—Estradiol—osteoporosis	4.37e-05	0.000274	CcSEcCtD
Paclitaxel—Vomiting—Ethinyl Estradiol—osteoporosis	4.37e-05	0.000273	CcSEcCtD
Paclitaxel—Diarrhoea—Pamidronate—osteoporosis	4.35e-05	0.000272	CcSEcCtD
Paclitaxel—Skin disorder—Estradiol—osteoporosis	4.35e-05	0.000272	CcSEcCtD
Paclitaxel—Hyperhidrosis—Estradiol—osteoporosis	4.33e-05	0.000271	CcSEcCtD
Paclitaxel—Rash—Ethinyl Estradiol—osteoporosis	4.33e-05	0.000271	CcSEcCtD
Paclitaxel—Dermatitis—Ethinyl Estradiol—osteoporosis	4.33e-05	0.000271	CcSEcCtD
Paclitaxel—Headache—Ethinyl Estradiol—osteoporosis	4.3e-05	0.000269	CcSEcCtD
Paclitaxel—Hypersensitivity—Zoledronate—osteoporosis	4.28e-05	0.000268	CcSEcCtD
Paclitaxel—Vomiting—Risedronate—osteoporosis	4.26e-05	0.000266	CcSEcCtD
Paclitaxel—Rash—Risedronate—osteoporosis	4.22e-05	0.000264	CcSEcCtD
Paclitaxel—Dermatitis—Risedronate—osteoporosis	4.22e-05	0.000264	CcSEcCtD
Paclitaxel—Dizziness—Pamidronate—osteoporosis	4.21e-05	0.000263	CcSEcCtD
Paclitaxel—Headache—Risedronate—osteoporosis	4.19e-05	0.000262	CcSEcCtD
Paclitaxel—Asthenia—Zoledronate—osteoporosis	4.17e-05	0.000261	CcSEcCtD
Paclitaxel—Hypersensitivity—Conjugated Estrogens—osteoporosis	4.12e-05	0.000258	CcSEcCtD
Paclitaxel—Pruritus—Zoledronate—osteoporosis	4.11e-05	0.000257	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Estradiol—osteoporosis	4.08e-05	0.000255	CcSEcCtD
Paclitaxel—Nausea—Ethinyl Estradiol—osteoporosis	4.08e-05	0.000255	CcSEcCtD
Paclitaxel—Insomnia—Estradiol—osteoporosis	4.05e-05	0.000254	CcSEcCtD
Paclitaxel—Vomiting—Pamidronate—osteoporosis	4.05e-05	0.000253	CcSEcCtD
Paclitaxel—Paraesthesia—Estradiol—osteoporosis	4.02e-05	0.000252	CcSEcCtD
Paclitaxel—Asthenia—Conjugated Estrogens—osteoporosis	4.02e-05	0.000251	CcSEcCtD
Paclitaxel—Rash—Pamidronate—osteoporosis	4.01e-05	0.000251	CcSEcCtD
Paclitaxel—Dermatitis—Pamidronate—osteoporosis	4.01e-05	0.000251	CcSEcCtD
Paclitaxel—Dyspnoea—Estradiol—osteoporosis	3.99e-05	0.00025	CcSEcCtD
Paclitaxel—Headache—Pamidronate—osteoporosis	3.99e-05	0.000249	CcSEcCtD
Paclitaxel—Somnolence—Estradiol—osteoporosis	3.98e-05	0.000249	CcSEcCtD
Paclitaxel—Diarrhoea—Zoledronate—osteoporosis	3.98e-05	0.000249	CcSEcCtD
Paclitaxel—Nausea—Risedronate—osteoporosis	3.98e-05	0.000249	CcSEcCtD
Paclitaxel—Pruritus—Conjugated Estrogens—osteoporosis	3.96e-05	0.000248	CcSEcCtD
Paclitaxel—Dyspepsia—Estradiol—osteoporosis	3.94e-05	0.000247	CcSEcCtD
Paclitaxel—Decreased appetite—Estradiol—osteoporosis	3.89e-05	0.000244	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Estradiol—osteoporosis	3.87e-05	0.000242	CcSEcCtD
Paclitaxel—Fatigue—Estradiol—osteoporosis	3.86e-05	0.000242	CcSEcCtD
Paclitaxel—Dizziness—Zoledronate—osteoporosis	3.84e-05	0.000241	CcSEcCtD
Paclitaxel—Constipation—Estradiol—osteoporosis	3.83e-05	0.00024	CcSEcCtD
Paclitaxel—Pain—Estradiol—osteoporosis	3.83e-05	0.00024	CcSEcCtD
Paclitaxel—Diarrhoea—Conjugated Estrogens—osteoporosis	3.83e-05	0.00024	CcSEcCtD
Paclitaxel—Nausea—Pamidronate—osteoporosis	3.78e-05	0.000237	CcSEcCtD
Paclitaxel—Dizziness—Conjugated Estrogens—osteoporosis	3.7e-05	0.000232	CcSEcCtD
Paclitaxel—Vomiting—Zoledronate—osteoporosis	3.7e-05	0.000231	CcSEcCtD
Paclitaxel—Feeling abnormal—Estradiol—osteoporosis	3.69e-05	0.000231	CcSEcCtD
Paclitaxel—Rash—Zoledronate—osteoporosis	3.67e-05	0.000229	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Estradiol—osteoporosis	3.66e-05	0.000229	CcSEcCtD
Paclitaxel—Dermatitis—Zoledronate—osteoporosis	3.66e-05	0.000229	CcSEcCtD
Paclitaxel—Headache—Zoledronate—osteoporosis	3.64e-05	0.000228	CcSEcCtD
Paclitaxel—Vomiting—Conjugated Estrogens—osteoporosis	3.56e-05	0.000223	CcSEcCtD
Paclitaxel—Urticaria—Estradiol—osteoporosis	3.56e-05	0.000223	CcSEcCtD
Paclitaxel—Abdominal pain—Estradiol—osteoporosis	3.54e-05	0.000222	CcSEcCtD
Paclitaxel—Body temperature increased—Estradiol—osteoporosis	3.54e-05	0.000222	CcSEcCtD
Paclitaxel—Rash—Conjugated Estrogens—osteoporosis	3.53e-05	0.000221	CcSEcCtD
Paclitaxel—Dermatitis—Conjugated Estrogens—osteoporosis	3.53e-05	0.000221	CcSEcCtD
Paclitaxel—Headache—Conjugated Estrogens—osteoporosis	3.51e-05	0.000219	CcSEcCtD
Paclitaxel—Nausea—Zoledronate—osteoporosis	3.45e-05	0.000216	CcSEcCtD
Paclitaxel—Nausea—Conjugated Estrogens—osteoporosis	3.33e-05	0.000208	CcSEcCtD
Paclitaxel—Hypersensitivity—Estradiol—osteoporosis	3.3e-05	0.000207	CcSEcCtD
Paclitaxel—Asthenia—Estradiol—osteoporosis	3.21e-05	0.000201	CcSEcCtD
Paclitaxel—Pruritus—Estradiol—osteoporosis	3.17e-05	0.000198	CcSEcCtD
Paclitaxel—Diarrhoea—Estradiol—osteoporosis	3.07e-05	0.000192	CcSEcCtD
Paclitaxel—Dizziness—Estradiol—osteoporosis	2.96e-05	0.000185	CcSEcCtD
Paclitaxel—Vomiting—Estradiol—osteoporosis	2.85e-05	0.000178	CcSEcCtD
Paclitaxel—Rash—Estradiol—osteoporosis	2.82e-05	0.000177	CcSEcCtD
Paclitaxel—Dermatitis—Estradiol—osteoporosis	2.82e-05	0.000177	CcSEcCtD
Paclitaxel—Headache—Estradiol—osteoporosis	2.81e-05	0.000176	CcSEcCtD
Paclitaxel—Nausea—Estradiol—osteoporosis	2.66e-05	0.000166	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—ACP5—osteoporosis	1.05e-05	9.45e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—DKK1—osteoporosis	1.05e-05	9.44e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—IDH2—osteoporosis	1.04e-05	9.4e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ENO1—osteoporosis	1.03e-05	9.34e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.03e-05	9.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—IDH2—osteoporosis	1.03e-05	9.32e-05	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.03e-05	9.32e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—IGF1—osteoporosis	1.03e-05	9.27e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.02e-05	9.21e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PSMA2—osteoporosis	1.02e-05	9.2e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PSMA5—osteoporosis	1.02e-05	9.2e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TPI1—osteoporosis	1.01e-05	9.13e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—WNT1—osteoporosis	1.01e-05	9.09e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TPI1—osteoporosis	1.01e-05	9.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GPD2—osteoporosis	1e-05	9.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PGLS—osteoporosis	1e-05	9.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1e-05	9.05e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	9.99e-06	9.02e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AGER—osteoporosis	9.88e-06	8.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	9.88e-06	8.92e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ADCY5—osteoporosis	9.85e-06	8.89e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TNF—osteoporosis	9.8e-06	8.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGA—osteoporosis	9.79e-06	8.85e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP27A1—osteoporosis	9.79e-06	8.84e-05	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MYC—osteoporosis	9.76e-06	8.82e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ENO1—osteoporosis	9.73e-06	8.79e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TPI1—osteoporosis	9.73e-06	8.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP27A1—osteoporosis	9.7e-06	8.76e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PSMA2—osteoporosis	9.59e-06	8.66e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PSMA5—osteoporosis	9.59e-06	8.66e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ACP5—osteoporosis	9.52e-06	8.6e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—P4HB—osteoporosis	9.5e-06	8.58e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—P4HB—osteoporosis	9.46e-06	8.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.44e-06	8.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ACP5—osteoporosis	9.44e-06	8.53e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GAPDH—osteoporosis	9.33e-06	8.42e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GAPDH—osteoporosis	9.29e-06	8.39e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PKM—osteoporosis	9.22e-06	8.32e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—FDPS—osteoporosis	9.22e-06	8.32e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PNP—osteoporosis	9.17e-06	8.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ATIC—osteoporosis	9.17e-06	8.28e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—P4HB—osteoporosis	9.15e-06	8.26e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—POMC—osteoporosis	9.13e-06	8.24e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—RAP1A—osteoporosis	9.08e-06	8.2e-05	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—osteoporosis	9.05e-06	8.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—RAP1A—osteoporosis	9.04e-06	8.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CA2—osteoporosis	9e-06	8.13e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—OXCT1—osteoporosis	9e-06	8.13e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GAPDH—osteoporosis	8.98e-06	8.11e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.97e-06	8.1e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TPI1—osteoporosis	8.85e-06	8e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TPI1—osteoporosis	8.78e-06	7.93e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MGLL—osteoporosis	8.77e-06	7.92e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—RAP1A—osteoporosis	8.75e-06	7.9e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GPD2—osteoporosis	8.74e-06	7.89e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PGLS—osteoporosis	8.74e-06	7.89e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ENO1—osteoporosis	8.73e-06	7.88e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	8.64e-06	7.81e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IRS2—osteoporosis	8.62e-06	7.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PKM—osteoporosis	8.61e-06	7.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—FDPS—osteoporosis	8.61e-06	7.78e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PSMA2—osteoporosis	8.6e-06	7.77e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PSMA5—osteoporosis	8.6e-06	7.77e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—P4HB—osteoporosis	8.32e-06	7.52e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—osteoporosis	8.28e-06	7.47e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CYP19A1—osteoporosis	8.27e-06	7.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—P4HB—osteoporosis	8.25e-06	7.45e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GAPDH—osteoporosis	8.17e-06	7.38e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GPD2—osteoporosis	8.16e-06	7.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PGLS—osteoporosis	8.16e-06	7.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GAPDH—osteoporosis	8.1e-06	7.31e-05	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MYC—osteoporosis	8.09e-06	7.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CALCA—osteoporosis	8.02e-06	7.24e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PNP—osteoporosis	7.99e-06	7.22e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ATIC—osteoporosis	7.99e-06	7.22e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—RAP1A—osteoporosis	7.96e-06	7.19e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.92e-06	7.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—RAP1A—osteoporosis	7.89e-06	7.12e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.89e-06	7.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CA2—osteoporosis	7.8e-06	7.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—OXCT1—osteoporosis	7.8e-06	7.04e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CYP19A1—osteoporosis	7.78e-06	7.03e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.63e-06	6.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MGLL—osteoporosis	7.6e-06	6.86e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IRS1—osteoporosis	7.52e-06	6.79e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PNP—osteoporosis	7.46e-06	6.74e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ATIC—osteoporosis	7.46e-06	6.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—IDH2—osteoporosis	7.46e-06	6.74e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MYC—osteoporosis	7.4e-06	6.68e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ENO1—osteoporosis	7.34e-06	6.63e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ENO1—osteoporosis	7.31e-06	6.6e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KL—osteoporosis	7.28e-06	6.57e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PSMA2—osteoporosis	7.24e-06	6.53e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PSMA5—osteoporosis	7.24e-06	6.53e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PSMA5—osteoporosis	7.2e-06	6.51e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PSMA2—osteoporosis	7.2e-06	6.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.17e-06	6.47e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ENO1—osteoporosis	7.07e-06	6.39e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6R—osteoporosis	7.07e-06	6.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP27A1—osteoporosis	7.01e-06	6.34e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PSMA5—osteoporosis	6.97e-06	6.29e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PSMA2—osteoporosis	6.97e-06	6.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ACP5—osteoporosis	6.82e-06	6.16e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—OXCT1—osteoporosis	6.79e-06	6.14e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CA2—osteoporosis	6.79e-06	6.14e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ADCY5—osteoporosis	6.75e-06	6.1e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GPX1—osteoporosis	6.73e-06	6.08e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MGLL—osteoporosis	6.62e-06	5.98e-05	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—MYC—osteoporosis	6.62e-06	5.98e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—IDH2—osteoporosis	6.46e-06	5.84e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ENO1—osteoporosis	6.43e-06	5.81e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ENO1—osteoporosis	6.38e-06	5.76e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ADCY5—osteoporosis	6.36e-06	5.74e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—OXCT1—osteoporosis	6.35e-06	5.73e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CA2—osteoporosis	6.35e-06	5.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TPI1—osteoporosis	6.34e-06	5.73e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PSMA2—osteoporosis	6.34e-06	5.73e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PSMA5—osteoporosis	6.34e-06	5.73e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GPX1—osteoporosis	6.34e-06	5.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PSMA2—osteoporosis	6.28e-06	5.67e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PSMA5—osteoporosis	6.28e-06	5.67e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—MTHFR—osteoporosis	6.21e-06	5.61e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MGLL—osteoporosis	6.19e-06	5.59e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP27A1—osteoporosis	6.08e-06	5.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—POMC—osteoporosis	6.02e-06	5.44e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—P4HB—osteoporosis	5.96e-06	5.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ACP5—osteoporosis	5.91e-06	5.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GAPDH—osteoporosis	5.85e-06	5.29e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—MTHFR—osteoporosis	5.85e-06	5.28e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP19A1—osteoporosis	5.84e-06	5.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.84e-06	5.27e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.83e-06	5.27e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ADCY5—osteoporosis	5.7e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—RAP1A—osteoporosis	5.7e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PKM—osteoporosis	5.68e-06	5.13e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FDPS—osteoporosis	5.68e-06	5.13e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP19A1—osteoporosis	5.65e-06	5.11e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—IDH2—osteoporosis	5.63e-06	5.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TPI1—osteoporosis	5.49e-06	4.96e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—osteoporosis	5.4e-06	4.88e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PGLS—osteoporosis	5.38e-06	4.86e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPD2—osteoporosis	5.38e-06	4.86e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL1B—osteoporosis	5.37e-06	4.85e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP27A1—osteoporosis	5.29e-06	4.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—IDH2—osteoporosis	5.26e-06	4.75e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTHFR—osteoporosis	5.24e-06	4.74e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.19e-06	4.69e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.18e-06	4.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—P4HB—osteoporosis	5.17e-06	4.67e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ACP5—osteoporosis	5.15e-06	4.65e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP19A1—osteoporosis	5.14e-06	4.64e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP19A1—osteoporosis	5.1e-06	4.6e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GAPDH—osteoporosis	5.07e-06	4.58e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IRS2—osteoporosis	4.99e-06	4.51e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—POMC—osteoporosis	4.97e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP27A1—osteoporosis	4.94e-06	4.47e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—RAP1A—osteoporosis	4.94e-06	4.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ATIC—osteoporosis	4.92e-06	4.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PNP—osteoporosis	4.92e-06	4.45e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.85e-06	4.38e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.84e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ACP5—osteoporosis	4.81e-06	4.34e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ADCY5—osteoporosis	4.8e-06	4.33e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TPI1—osteoporosis	4.79e-06	4.32e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GPX1—osteoporosis	4.78e-06	4.32e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ADCY5—osteoporosis	4.78e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GPX1—osteoporosis	4.76e-06	4.3e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.75e-06	4.29e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—POMC—osteoporosis	4.68e-06	4.22e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ADCY5—osteoporosis	4.62e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ENO1—osteoporosis	4.61e-06	4.16e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GPX1—osteoporosis	4.6e-06	4.16e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PSMA2—osteoporosis	4.54e-06	4.1e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PSMA5—osteoporosis	4.54e-06	4.1e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—P4HB—osteoporosis	4.5e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TPI1—osteoporosis	4.47e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GAPDH—osteoporosis	4.42e-06	3.99e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—MTHFR—osteoporosis	4.41e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—MTHFR—osteoporosis	4.39e-06	3.97e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IRS1—osteoporosis	4.36e-06	3.93e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.31e-06	3.89e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—RAP1A—osteoporosis	4.3e-06	3.89e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—MTHFR—osteoporosis	4.25e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—P4HB—osteoporosis	4.2e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ADCY5—osteoporosis	4.2e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GPX1—osteoporosis	4.19e-06	3.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA2—osteoporosis	4.19e-06	3.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—OXCT1—osteoporosis	4.19e-06	3.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ADCY5—osteoporosis	4.17e-06	3.76e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GPX1—osteoporosis	4.15e-06	3.75e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GAPDH—osteoporosis	4.13e-06	3.73e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6R—osteoporosis	4.09e-06	3.7e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MGLL—osteoporosis	4.08e-06	3.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—RAP1A—osteoporosis	4.02e-06	3.63e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ENO1—osteoporosis	3.99e-06	3.61e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PSMA2—osteoporosis	3.93e-06	3.55e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PSMA5—osteoporosis	3.93e-06	3.55e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MTHFR—osteoporosis	3.86e-06	3.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MTHFR—osteoporosis	3.83e-06	3.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP19A1—osteoporosis	3.68e-06	3.33e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—POMC—osteoporosis	3.53e-06	3.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—POMC—osteoporosis	3.51e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.51e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO1—osteoporosis	3.48e-06	3.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH2—osteoporosis	3.47e-06	3.13e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PSMA5—osteoporosis	3.43e-06	3.1e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PSMA2—osteoporosis	3.43e-06	3.1e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—POMC—osteoporosis	3.4e-06	3.07e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.26e-06	2.95e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO1—osteoporosis	3.25e-06	2.93e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PSMA5—osteoporosis	3.2e-06	2.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PSMA2—osteoporosis	3.2e-06	2.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP19A1—osteoporosis	3.19e-06	2.88e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ACP5—osteoporosis	3.17e-06	2.87e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—osteoporosis	3.15e-06	2.84e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—POMC—osteoporosis	3.09e-06	2.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—POMC—osteoporosis	3.06e-06	2.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ADCY5—osteoporosis	3.01e-06	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GPX1—osteoporosis	3e-06	2.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TPI1—osteoporosis	2.95e-06	2.66e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP19A1—osteoporosis	2.78e-06	2.51e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—P4HB—osteoporosis	2.77e-06	2.5e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—osteoporosis	2.77e-06	2.5e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GAPDH—osteoporosis	2.72e-06	2.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—RAP1A—osteoporosis	2.65e-06	2.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ADCY5—osteoporosis	2.61e-06	2.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GPX1—osteoporosis	2.6e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.6e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—osteoporosis	2.42e-06	2.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—osteoporosis	2.42e-06	2.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—osteoporosis	2.4e-06	2.17e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ADCY5—osteoporosis	2.27e-06	2.05e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GPX1—osteoporosis	2.26e-06	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—POMC—osteoporosis	2.21e-06	2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO1—osteoporosis	2.14e-06	1.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ADCY5—osteoporosis	2.12e-06	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GPX1—osteoporosis	2.12e-06	1.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PSMA2—osteoporosis	2.11e-06	1.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PSMA5—osteoporosis	2.11e-06	1.91e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—osteoporosis	2.09e-06	1.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—osteoporosis	1.95e-06	1.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—POMC—osteoporosis	1.92e-06	1.73e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—osteoporosis	1.82e-06	1.65e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.71e-06	1.55e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—POMC—osteoporosis	1.67e-06	1.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—POMC—osteoporosis	1.56e-06	1.41e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ADCY5—osteoporosis	1.4e-06	1.26e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPX1—osteoporosis	1.39e-06	1.26e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—osteoporosis	1.29e-06	1.16e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—POMC—osteoporosis	1.03e-06	9.3e-06	CbGpPWpGaD
